H-FIASNGVKLV-OH

Ref. 3D-PP48294

Informations sur le produit

• Nom: H-FIASNGVKLV-OH

Description

Peptide H-FIASNGVKLV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FIASNGVKLV-OH include the following: A three-dimensional tumor cell defect in activating autologous CTLs is associated with inefficient antigen presentation correlated with heat shock protein-70 down V Dangles-Marie, S Richon, M El Behi , H Echchakir - Cancer research, 2003 - AACRhttps://aacrjournals.org/cancerres/article-abstract/63/13/3682/510167 Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution H Echchakir, G Dorothee, I Vergnon - Proceedings of the , 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.142308199 A Point Mutation in the alpha-Actinin-4 Gene Generates an Antigenic Peptide Recognized by Autologous Cytolytic T Lymphocytes on a Human Lung Carcinoma H Echchakir, F Mami-Chouaib, I Vergnon, JF Baurain - Cancer research, 2001 - AACRhttps://aacrjournals.org/cancerres/article-abstract/61/10/4078/507442 Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death G Friedlein, F El Hage, I Vergnon, C Richon - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/178/11/6821/42977 In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity G Dorothee, I Vergnon, F El Hage - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/11/6888/101552 Prediction of MHC class I binding peptides using Fourier analysis and support vector machine F Shi, Q Chen - International Conference on Fuzzy Systems and , 2006 - Springerhttps://link.springer.com/chapter/10.1007/11881599_133 Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen F Mami-Chouaib, H Echchakir, G Dorothee - Immunological , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1600-065X.2002.18810.x Generation of diverse mutated tumor antigen-specific cytotoxic T lymphocytes in a lung cancer patient with long survival F El Hage, I Vergnon, D Grunenwald - Oncology , 2005 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/or.14.3.763 Human CD5 Protects Circulating Tumor AIC Death, CTL Antigen-Specific - J Immunol, 2007 - academia.eduhttps://www.academia.edu/download/42181226/6821.pdf

• Marque: Biosynth